Everest Organics Ltd.

124.60 -2.35 ▼-1.9%

08 December 2023, 04:01:00 PM
Volume: 3,990

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.everestorganicsltd.com
Market Cap 98.96 Cr.
Enterprise Value(EV) 150.64 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 2.12 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) 58.38 Trailing Twelve Months Ending 2023-09
Industry PE 38.52 Trailing Twelve Months Ending 2023-09
Book Value / Share 57.85 Trailing Twelve Months Ending 2023-09
Price to Book Value 2.14 Calculated using Price: 123.70
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.80 Cr. 8,000,000 Shares
FaceValue 10
About Everest Organics Ltd.
The company's facilities comply to GMP standards and is certified by the Drug Control Authority of the Government of Andhra Pradesh, India. It supply products to major multinational companies abroad, prominent well established formulation companies in India, Europe, USA, Far East and the Middle East, and also to Latin / Central / South American Countries. The company also provides adequate technical & documentary support for their products and its products comply to various pharmacopial standards like BP, USP, EP and IP Standards as desired by the customer.

Everest Organics Ltd. Delivery

Delivered Qty
Traded Qty

Everest Organics Ltd. Performance

1 Day
-1.85%
1 Week
-2.12%
1 Month
+5.59%
3 Month
-5.78%
6 Month
+26.65%
1 Year
-1.81%
2 Year
-53.32%
5 Year
+37.83%
10 Year

Everest Organics Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 33.19 3.06 12.25 9.86 33.63 36.22 33.96 2.45 -0.39
Return on Capital Employed (%) 15.84 8.90 13.55 13.80 35.30 35.22 33.76 6.25 3.72
Return on Assets (%) 2.50 0.25 1.67 1.90 7.45 9.58 10.73 0.73 -0.10

Everest Organics Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 6 6 16 19 26 34 47 47 46 46
Non Curr. Liab. 11 14 7 8 10 12 11 19 18 17
Curr. Liab. 50 56 63 67 71 74 77 113 138 157
Minority Int.
Equity & Liab. 67 76 86 94 107 120 135 178 202 220
Non Curr. Assets 25 29 37 36 40 41 46 60 69 74
Curr. Assets 42 47 49 58 67 79 89 118 132 147
Misc. Exp. not W/O
Total Assets 67 76 86 94 107 120 135 178 202 220

Everest Organics Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 106 99 107 112 156 167 182 200 183 186
Other Income 1 1 1 1 1 1 1 2 7 7
Total Income 107 100 108 113 156 169 183 202 190 193
Total Expenditure -98 -94 -101 -105 -138 -148 -159 -194 -182 -181
PBIDT 8 6 7 8 18 21 24 9 8 12
Interest -3 -3 -3 -3 -3 -3 -3 -3 -3 -5
Depreciation -3 -3 -2 -3 -3 -3 -3 -4 -4 -5
Taxation 0 0 0 -1 -5 -3 -4 -1 0 -1
Exceptional Items -1 -1
PAT 2 0 1 2 8 11 14 1 0 2
Adjusted EPS 2 1 2 2 9 14 17 1 0 2

Everest Organics Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 1 4 7 10 5 9 10 14 14 18
Cash Fr. Inv. -3 -3 -7 -8 -4 -5 -6 -12 -17 -16
Cash Fr. Finan. 2 -2 0 -2 0 -3 -3 -2 2 -3
Net Change 0 0 0 0 1 1 0 0 -1 0
Cash & Cash Eqvt 1 1 1 1 1 2 2 2 1 1

Everest Organics Ltd. Shareholding Pattern

9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 74.15 74.15 74.15 74.15 74.15 74.15 74.15 74.15 74.15
Public 25.85 25.85 25.85 25.85 25.85 25.85 25.85 25.85 25.85
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Everest Organics Ltd. Announcements

Sat, 09 Dec 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please see attached enclosure.
Sat, 09 Dec 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please see attached enclosure.
Sat, 09 Dec 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please see attached enclosure.

Everest Organics Ltd. Technical Scans

Fri, 08 Dec 2023
Closing Below Previous Low Closing Below Previous Low
High Increase in 6 Months High Increase in 6 Months
High Decrease in 2 Years High Decrease in 2 Years
William %R Trending Down William %R Trending Down
Thu, 07 Dec 2023
High Increase in 1 Month High Increase in 1 Month

Everest Organics Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 296,437.84 1,235.50 -0.3%
Cipla Ltd. 98,444.27 1,218.85 -0.3%
Divi's Laboratories Ltd. 97,728.28 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. 96,135.30 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. 79,790.42 5,542.00 +1.5%
Mankind Pharma Ltd. 78,250.95 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. 69,508.23 2,056.00 -2.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.68 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-09 28.51 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-09 73.38 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.88 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 114.40 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 61.04 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 52.11 2,056.00 -2.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.96 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-09 3.97 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-09 7.71 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.77 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.27 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 9.28 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.36 2,056.00 -2.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,056.00 -2.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,056.00 -2.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,056.00 -2.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,056.00 -2.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,056.00 -2.2%

Everest Organics Ltd. FAQ's

What is Everest Organics share price?

Can I buy Everest Organics shares now?

What is the Market Cap of Everest Organics?

What are the key metrics to analyse Everest Organics?

What is the 52 Week High and Low of Everest Organics?

What is the trend of Everest Organics share price?